Outdoor High Performance) 8 18% 3 Growth in Asia / LATAM 6 3% 2 Other 100 19% 5 Sub-total $1,327 14% $146 Outdoor High Performance Impact (5) (3) Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 5 Incentives, Other Employee Costs 8 FX (28) (5) Q1 2022 $1,294 11% $136 Q1 2022 SALES AND OPERATING INCOME ( T O TA L C O M PA N Y ) 6 Sales Growth Rate Adjusted Operating Income$ millions Adjusted EBITDA Q1 EBITDA BRIDGE 7 Price increases more than offset raw material and supply chain impacts Q1 2021 $ 161 Demand (23) $ millions CAI: Price / Mix 77 Inflation (54) SEM: Price / Mix 41 Inflation (26) Distribution: Price / Mix 84 Inflation (82) Net Price Benefit 40 Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 5 Incentives, Other Employee Costs 8 FX (5) Q1 2022 $ 171    China Lockdowns / Russia Impact $ (7) Transportation (7) Outdoor High Performance (3) Q1 EPS BRIDGE 8 Q1 2021 - Adjusted EPS 0.89$ CAI 0.08 Specialty Engineered Materials 0.06 Distribution 0.00 Corporate Costs 0.02 F/X (0.04) Segment OI 0.12 Tax Rate (0.02) Q1 2022 - Adjusted EPS 0.99$ 10 15x stronger than steel Reduces weight by 30% vs. other solutions Well-maintained global asset base poised to serve growing demand • Purchase price of $1.48B represents 11.4x multiple of 2022 EBITDA • Acquisition will expand Avient’s composites and fiber portfolio with Dyneema®, the World’s Strongest Fiber™ • $415M sales and 30%+ EBITDA margins; Immediately accretive to pro forma 2022 EPS, adding $0.35 • 1,300 patents globally, ~50% of sales patent protected • 1,000+ employees across global production network and dedicated technology centers • Composites platform will increase from $261M to $680M in revenue and from $49M to $180M in EBITDA Indicates Dyneema ® location $175M (42%) $65M (16%) $175M (42%) 2022E Sales By Region ($M) (1) $0.35 EPS excludes intangible amortization (2) Based on 2022 expected results (1) (2) (2) F I T W I T H F O U R P I L L A R S T R AT E G Y 11 Specialization • Innovation-led organization with tremendous intellectual property value in trademarks, patents and “know-how” • Deep history of application development and premium, leading brand with the World’s Strongest FiberTM Globalization • Global customer base with an established presence across all major geographic regions • Global technology centers complement existing Composites applications and expertise Operational Excellence • Best-in-class safety performance • Well-run and maintained asset base fit to serve future growth • Highly effective and reliable supply chain with emphasis on optimizing service to customers Commercial Excellence • Deep customer relationships extend across the value chain and drive ability to grow • Offer a full suite of services with an active role in design, development and commercialization People Experienced and talented associates with a passion for safety, specialization and winning DY N E E M A ® OV E RV I E W K E Y I N D U S T R I E S PERSONAL PROTECTION Military • Law Enforcement • First Responders Body Armor • Helmets • Vehicle Protection $215M MARINE & SUSTAINABLE INFRASTRUCTURE Towing / Mooring • Aquaculture • Floating Wind • Offshore Cranes $130M CONSUMER Consumer • Outdoor High Performance • Safety Equipment $70M 12 Figures reflect 2022 expected sales MIFOverview Competition Value chain & Go-to-market Strategy Innovation Financials TECHNOLOGY 13 1,200 1,300 2,500 Avient Dyneema Combined Patents • True specialty business – the World’s Strongest Fiber™ • Deep history of application development with customers, strongest in the industry • The only UHMwPE (ultra-high molecular weight polyethylene) fiber producer that is backward integrated o Provides innovation advantage through control of all steps of the process • Complementary with our existing reinforced film expertise (PolyStrand) and engineered fiber presences (Fiber-Line) WINNING PROPERTIES Ultra high strength vs. weight Highly flexible Floats on water Chemically inert; no smell/taste and non-toxic High resistance to UV radiation Self-lubricating, with low friction One-of-a-kind technology ® FORMULATION PROCESS 14 • Like Avient, Dyneema® offers similar core competencies around formulation and material science • Technology that combines polymers and fibers to provide specialized, high performing solutions for customers • Design capabilities ensure that applications are highly customized for the specified end use DYNEEMA ® IN THE VALUE CHAIN 15 UHMwPE Fiber / Tapes Military Personnel, Law Enforcement Heavy Marine, Offshore Wind Energy and Mooring, Aquaculture Outdoor, Footwear, Apparel, Inflatables • Material Science • Formulation • Service INTERMEDIATE MANUFACTURING (CUSTOMERS) OEM / APPLICATION DEMAND TRENDS 16 • Military spending and near-term demand for higher performing personal protection products (like Dyneema®) expected to increase o European NATO members annual defense spend expected to increase by up to 20%(1) o Accelerated launch of next generation technology in North America • Policy-driven demand for sustainable energy; growth in floating offshore wind farms which require advanced, durable technology o Offshore wind expected to grow at a CAGR of 32% with the level of annual installations quadrupling over the next five years(2) • Continued investment in aquaculture as a sustainable food source(3) • Strong demand in outdoor high performance space across niche consumer applications aligns with 10% growth assumption for Avient’s Composites portfolio Sources: (1) “Funding NATO”, NATO.int (April 1, 2022) (2) “Global Wind Report 2021”, Global Wind Energy Council (3) “Aquaculture Supports a Sustainable Earth”, NOAA Fisheries 17 A L I G N M E N T W I T H S U S T A I N A B I L I T Y G O A L S P RO D U C T S AVIE NT ’S E XIS T ING COM P OS IT E S P ORT F OL IO D I V E R S E C A P A B I L I T I E S A N D S O L U T I O N S S E R V I N G M A N U F A C T U R E R S A N D O E M S LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 18 AV I E N T ’ S C O M P O S I T E S P O RT F O L I O S A L E S A N D E B I T DA 19 $74 $84 $216 $212 $261 $5 $10 $32 $41 $49 $180 0 50 100 150 200 $- $50 $100 $150 $200 $250 $300 $350 $400 $450 $500 $550 $600 $650 $700 $750 2017 2018 2019 2020 2021 2022E $680 ($ in millions) • Dyneema® acquisition will further improve Composites EBITDA margins to 26% • Dyneema® will complement our existing portfolio with deep formulation expertise, innovative culture and global commercial presence • Composites will continue to be a key growth driver to deliver future revenue growth in excess of GDP (1) Pro forma for the acquisition of Dyneema® (1) D I S T R I BU T I O N D I V E S T I T U R E C O N S I D E R AT I O N S D I S T R I BU T I O N H I G H L I G H T S 21 $21 $57 $69 $94 $105 0 50 100 150 2006 2011 2016 2021 2022E • Leading North American Distribution business with longstanding blue-chip supplier and customer relationships • Commercial excellence and regulatory knowledge have grown healthcare portfolio to over 25% of sales and positioned business for long-term growth • Highly specialized portfolio of engineered polymers along with sustainable solution offerings • Leading digital capabilities through Avient Now, allowing enhanced visibility and 24/7 interface with customers • 98% free cash flow conversion drives greater than 30% after-tax return on invested capital (ROIC) • Potential divestiture allows us to remain modestly leveraged with net debt to adjusted EBITDA expected to be 2.9x and positions us for further specialty growth in the future EBITDA (in $M) DY N E E M A ® T R A N S AC T I O N OV E RV I E W 22 - $1.48B net purchase price - Represents 11.4x expected 2022 EBITDA - Committed financing in place - Permanent financing to be combination of available cash on-hand, new Senior Unsecured Notes, new Senior Secured Term Loan - Potential proceeds from Distribution divestment could be used to pay down near-term maturing debt - Closing expected in second half of 2022, subject to regulatory approvals and certain customary closing conditions Transaction Value Financing Closing Conditions / Timing C A P I TA L S T RU C T U R E / L E V E R AG E 23 • Financing commitments secured from Morgan Stanley and J.P. Financials are pro forma for the acquisition of Dyneema® and potential divestiture of Distribution Avient Specialty Formulators Other Specialty / Chemical Companies 30 CULTURE AND PEOPLE 31 O U R S P E C I A LT Y J O U R N E Y C O N T I N U E S 32 • Dyneema® brings leading technology and brand with the World’s Strongest Fiber™, deep history of application development and strong management team focused on specialty applications • Dyneema® transaction is aligned with our previously stated acquisition goal of expanding our composites and fiber capabilities • Similar to our other technology expansion acquisitions, Dyneema® allows us to leverage our invest-to-grow strategy • We plan to explore a possible sale of our Distribution business. Three Months Ended March 31, 2022 Reconciliation to Condensed Consolidated Statements of Income GAAP Results Special Items Adjusted Results Operating Income $ 128.6 $ 7.8 $ 136.4 Income before income taxes $ 111.1 $ 7.7 $ 118.8 Income tax expense - GAAP (26.6) — (26.6) Income tax impact of special items — (2.0) (2.0) Tax adjustments — 1.5 1.5 Net income attributable to noncontrolling interests (0.3) — (0.3) Net income attributable to Avient shareholders $ 84.2 $ 7.2 $ 91.4 EPS $ 0.91 0.08 $ 0.99 Weighted-average diluted shares 92.3 92.3 92.3 1 Three Months Ended March 31, 2021 Reconciliation to Condensed Consolidated Statements of Income GAAP Results Special Items Adjusted Results Operating Income $ 120.4 $ 2.4 $ 122.8 Income before income taxes $ 102.6 $ 2.4 $ 105.0 Income tax expense - GAAP (22.9) — (22.9) Income tax impact of special items — (0.9) (0.9) Tax adjustments — 1.1 1.1 Net income attributable to noncontrolling interests (0.4) — (0.4) Net income attributable to Avient shareholders $ 79.3 $ 2.6 $ 81.9 EPS $ 0.86 0.03 $ 0.89 Weighted-average diluted shares 92.2 92.2 92.2 Year Ended December 31, 2021 Reconciliation to Condensed Consolidated Statements of Income GAAP Results Special Items Adjusted Results Operating income $ 381.2 $ 47.8 $ 429.0 Income from continuing operations before income taxes $ 304.6 $ 57.1 $ 361.7 Income tax expense - GAAP (74.0) — (74.0) Income tax impact of special items — (13.0) (13.0) Tax adjustments — 5.9 5.9 Net income attributable to noncontrolling interests 0.2 — 0.2 Net income from continuing operations attributable to Avient shareholders $ 230.8 $ 50.0 $ 280.8 EPS $ 2.51 0.54 $ 3.05 Weighted-average diluted shares 92.1 92.1 92.1 2 Reconciliation of EBITDA by Segment Three Months Ended March 31, Year Ended December 31, 2022 2021 2021 Operating income: Color, Additives and Inks $ 94.5 $ 88.8 $ 303.1 Specialty Engineered Materials 39.7 34.2 132.0 Distribution 24.2 24.0 93.2 Corporate and eliminations (29.8) (26.6) (147.1) Operating income $ 128.6 $ 120.4 $ 381.2 Items below OI in Corporate: Other income, net $ (0.6) $ 1.5 $ (1.3) Depreciation & amortization: Color, Additives and Inks $ 26.0 $ 27.4 $ 105.7 Specialty Engineered Materials 7.8 7.8 31.7 Distribution 0.2 0.2 0.8 Corporate and eliminations 3.8 1.7 7.7 Depreciation & Amortization $ 37.8 $ 37.1 $ 145.9 EBITDA: Color, Additives and Inks $ 120.5 $ 116.2 $ 408.8 Specialty Engineered Materials 47.5 42.0 163.7 Distribution 24.4 24.2 94.0 Corporate and eliminations (26.0) (24.9) (140.7) EBITDA $ 165.8 $ 159.0 $ 525.8 Reconciliation of Sales, Operating Income and EBITDA - Distribution Year Ended December 31, 2006 2011 2016 Sales $ 732.8 $ 996.5 $ 1,071.0 Operating income 19.2 56.0 68.2 Depreciation & amortization 1.5 0.7 0.7 EBITDA $ 20.7 $ 56.7 $ 68.9 3 Three Months Ended March 31, Year Ended December 31, Reconciliation to EBITDA and Adjusted EBITDA: 2022 2021 2021 Net income from continuing operations – GAAP $ 84.5 $ 79.7 $ 230.6 Income tax expense 26.6 22.9 74.0 Interest expense 16.9 19.3 75.3 Depreciation and amortization from continuing operations 37.8 37.1 145.9 EBITDA $ 165.8 $ 159.0 $ 525.8 Special items, before tax 7.7 2.4 57.1 Depreciation and amortization included in special items (2.1) (0.5) (1.7) Adjusted EBITDA $ 171.4 $ 160.9 $ 581.2 4 Masseto IR Presentation - Final.pdf Avient Corporation �specialty Portfolio Transformation Continues with Dyneema Acquisition DISCLAIMER Slide Number 3 Slide Number 4 Slide Number 5 Q1 2022 SALES AND OPERATING INCOME�(Total Company) Slide Number 7 Slide Number 8 Slide Number 9 Slide Number 10 FIT with Four Pillar Strategy Dyneema® overview Slide Number 13 Slide Number 14 Dyneema® in the Value Chain Demand trends Products Avient’s Existing Composites Portfolio Avient’s Composites Portfolio�Sales and Ebitda Distribution Divestiture Considerations Distribution highlights Dyneema® Transaction Overview Capital structure / Leverage Two-Year Leverage Goal Pro forma modeling Our Specialty Journey Acquisition History Clariant Color Acquisition Specialty Transformation 2022 ebitda margins vs. peers Culture and People Our Specialty Journey continues Slide Number 33 Avient Acquisition of Dyneema and Q1 2022 Results.pdf Masseto IR Presentation - 4.19 (515pm) - with attachments.pdf

Mevopur™ Healthcare Colorants and Formulations and Mevopur™ Healthcare Functional Additives for In Vitro Diagnostic Devices Diagnostic devices and consumables, now more than ever, play a vital role in delivery of safe treatements. KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Available as concentrates or ready-to-use formulations in a wide range of polymers • Functionality and color can be combined in one product for convenience REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Documentation support for approval or transition to comply with (new) regulations such as IVDR APPLICATION BULLETIN Healthcare use limitations apply—see below. FUNCTIONALITY TARGET APPLICATIONS BLOOD COLLECTION REAGENT CONTAINERS/ KITS PIPETTE/ LABWARE SELF-TESTING/ POCT INSTRUMENT/ ACCESSORIES Colorants for coding for lab automation/ identification Wide range of colors in various polymers, available in ready-to-use formulation or concentrate adapted to your process     Colors – low migration/ interference Ready-to-use formulation to avoid interference with analytical tests; extractable metal data    Colors – biologically evaluated Reduced risk of non compliance to current and proposed regulations such as IVDR     Color in PP, ABS, PC and high temperature polymers with UL listings Ready-to-use solutions/concentrates supporting Underwriters Laboratory requirements of electric enclosures   Antistatic for PP, ABS, PC/ABS Permanent/non-migrating ready-to-use formulation; fast decay time independent of % relative humidity   Clarifying PP Sorbitol-free, minimizing potential migration   Laser marking for UDI replacing ink printing/labels Activation of the polymer to laser energy give high contrast solvent-free, high speed identification     Laser welding for fast, reliable assembly of a range of polymers Custom concentrates and ready-to-use formulations for optically transparent and opaque colors while allowing laser transmission/absorption    Nucleation of semicrystalline polymers e.g.

They can do both with the right polymer materials. Specialty Engineered Polymers for Telecommunication Applications Specialty Engineered Polymers for Telecommunication Applications (Chinese)

serving in various sales, marketing and general manager roles focused on specialty markets while based in Few people have the combined credibility, vast experience and strong relationships in polymer distribution as is a premier provider of specialized polymer materials, services and solutions.

Home // Protecting Polymers from Microbe Growth Subsequent studies then assessed the use of an antimicrobial additive, zinc pyrithione (ZPT), for potential efficacy in a variety of TPE formulations for diverse applications.

is a premier provider of specialized polymer materials, services and solutions.       Specialty Platform       Specialty Platform

Our exceptional polymer scientists and design engineers are integral to their product development process. D is t. ) K W R R P M P P G A V Y F U L G C P H X L F M C F O E IF F H U N E C L A S H E M N K R A C E S C L G R A A L B Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of June 4, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. 29 We are a specialty formulator that enables many of the world’s products through innovation and custom solutions.

Back Home // Products // Polymer Colorants // Organoleptic Colorants & Additives // OnColor™ SenseAction™ Custom Colorants for Caps Masterbatch formulation based on dedicated raw material range SENSEACTION organoleptic pre-tested masterbatches are formulated to reduce negative organoleptic influences. 

Our exceptional polymer scientists and design engineers are integral to their product development process. D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A L B Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of April 27, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. 29 We are a specialty formulator that enables many of the world’s products through innovation and custom solutions.

Polymer Colorants Mevopur™ Healthcare Colorants and Formulations Mevopur™ Healthcare Colorants and Formulations